Irinotecan liposomal and Pancuronium
Determining the interaction of Irinotecan liposomal and Pancuronium and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Theoretically, irinotecan may antagonize the pharmacologic effect of nondepolarizing neuromuscular blocking agents due to its anticholinesterase activity, resulting in increased dosage requirements for adequate skeletal muscle relaxation. However, the interaction has not been studied or reported in a clinical setting.
- "Product Information. Camptosar (irinotecan)." Pharmacia and Upjohn, Kalamazoo, MI.
Generic Name: irinotecan liposomal
Brand name: Onivyde
Synonyms: Irinotecan (Liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Irinotecan liposomal-Pancuronium Bromide
- Irinotecan liposomal-Pandel
- Irinotecan liposomal-Pandel Topical application
- Irinotecan liposomal-Pangestyme EC
- Irinotecan liposomal-Panhematin
- Irinotecan liposomal-Panitumumab
- Pancuronium-Irinotecan liposome Intravenous
- Pancuronium-Iron 100/C
- Pancuronium-Iron 21/7
- Pancuronium-Iron and Docusate
- Pancuronium-Iron and Folic Acid
- Pancuronium-Iron and Vitamin C